跳至主要内容
临床试验/ISRCTN46117662
ISRCTN46117662已完成不适用

Comparison of the equivalence of ceftriane plus azithromycin or doxycycline for the treatment of pelvic inflammatory disease

Foundation for the Incentive of Research (Fundacao de Incentivo a Pesquisa) (FIPE) (Brazil)0 个研究点目标入组 112 人开始时间: 2006年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
112

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. A history of pelvic discomfort for a period of 30 days or less
  • 2. Findings of pelvic organ tenderness (uterine or adnexal) on bimanual examination
  • 3. Leukorrhea and/or mucopurulent cervicitis and/or untreated known positive gonococcal or chlamydial cervicitis

排除标准

  • 1. Current pregnancy as demonstrated by beta-Human Chorionic Gonadotrophin (HCG) or ultrasonography
  • 2. Inability to tolerate an outpatient oral regimen as demonstrated by the vomiting of eight ounces of water one hour after taking 10 mg of metoclopramide
  • 3. Presence of tubo-ovarian abscess, appendicitis or hemorrhagic ovarian cysts confirmed by ultrasound or laparoscopy
  • 4. Pelvic pain over 30 days duration
  • 5. Allergy to ceftriaxone, azithromycin or doxycycline
  • 6. Antimicrobial therapy within seven days of recruitment
  • 7. Delivery, abortion or gynecological surgery within 30 days
  • 8. Prior hysterectomy or bilateral salpingectomy
  • 9. Homelessness
  • 11. Abdominal rebound tenderness

研究者

发起方
Foundation for the Incentive of Research (Fundacao de Incentivo a Pesquisa) (FIPE) (Brazil)

相似试验